[go: up one dir, main page]

MXPA02006778A - Metodo para determinar la respuesta a una terapia de cancer. - Google Patents

Metodo para determinar la respuesta a una terapia de cancer.

Info

Publication number
MXPA02006778A
MXPA02006778A MXPA02006778A MXPA02006778A MXPA02006778A MX PA02006778 A MXPA02006778 A MX PA02006778A MX PA02006778 A MXPA02006778 A MX PA02006778A MX PA02006778 A MXPA02006778 A MX PA02006778A MX PA02006778 A MXPA02006778 A MX PA02006778A
Authority
MX
Mexico
Prior art keywords
response
determining
cancer therapy
individual
relates
Prior art date
Application number
MXPA02006778A
Other languages
English (en)
Inventor
Sarah S Bacus
Original Assignee
Ventana Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ventana Inc filed Critical Ventana Inc
Publication of MXPA02006778A publication Critical patent/MXPA02006778A/es

Links

Classifications

    • G01N33/575—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G01N33/5758—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/495—Transforming growth factor [TGF]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/82—Translation products from oncogenes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/101666—Particle count or volume standard or control [e.g., platelet count standards, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/105831—Protein or peptide standard or control [e.g., hemoglobin, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/13—Tracers or tags

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrotherapy Devices (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)

Abstract

La invencion se relaciona a un metodo para determinar la respuesta a una terapia de cancer en un individuo el cual usa analisis de imagen.
MXPA02006778A 2000-01-12 2001-01-12 Metodo para determinar la respuesta a una terapia de cancer. MXPA02006778A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17651400P 2000-01-12 2000-01-12
US17651500P 2000-01-12 2000-01-12
PCT/US2001/001113 WO2001051924A2 (en) 2000-01-12 2001-01-12 Method for determining the response to cancer therapy

Publications (1)

Publication Number Publication Date
MXPA02006778A true MXPA02006778A (es) 2004-04-05

Family

ID=26872320

Family Applications (2)

Application Number Title Priority Date Filing Date
MXPA02006843A MXPA02006843A (es) 2000-01-12 2001-01-12 Metodo para cuantificar una proteina por analisis de imagenes.
MXPA02006778A MXPA02006778A (es) 2000-01-12 2001-01-12 Metodo para determinar la respuesta a una terapia de cancer.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MXPA02006843A MXPA02006843A (es) 2000-01-12 2001-01-12 Metodo para cuantificar una proteina por analisis de imagenes.

Country Status (10)

Country Link
US (2) US7833698B2 (es)
EP (2) EP1247098A1 (es)
JP (2) JP3699399B2 (es)
AT (1) ATE271691T1 (es)
AU (2) AU2951801A (es)
CA (2) CA2397417A1 (es)
DE (1) DE60104392T2 (es)
DK (1) DK1247097T3 (es)
MX (2) MXPA02006843A (es)
WO (2) WO2001051928A1 (es)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050100542A1 (en) * 1999-10-08 2005-05-12 Young David S. Cytotoxicity mediation of cells evidencing surface expression of CD44
CA2406443C (en) * 2000-04-14 2009-06-23 Ventana Medical Systems, Inc. Method for quantification of akt protein expression
US20040085443A1 (en) * 2000-12-13 2004-05-06 Kallioniemi Olli P Method and system for processing regions of interest for objects comprising biological material
ATE530635T1 (de) 2001-08-21 2011-11-15 Ventana Med Syst Inc Verfahren und quantifizierungsassay zur bestimmung des c-kit/scf/pakt-status
GB0218909D0 (en) * 2002-08-15 2002-09-25 Qinetiq Ltd Histological assessment
US20030165263A1 (en) * 2002-02-19 2003-09-04 Hamer Michael J. Histological assessment
US7648678B2 (en) 2002-12-20 2010-01-19 Dako Denmark A/S Method and system for pretreatment of tissue slides
GB0229734D0 (en) * 2002-12-23 2003-01-29 Qinetiq Ltd Grading oestrogen and progesterone receptors expression
DK1636585T3 (da) * 2003-05-20 2008-05-26 Bayer Pharmaceuticals Corp Diarylurinstoffer med kinasehæmmende aktivitet
US20050112622A1 (en) * 2003-08-11 2005-05-26 Ring Brian Z. Reagents and methods for use in cancer diagnosis, classification and therapy
US20080113874A1 (en) * 2004-01-23 2008-05-15 The Regents Of The University Of Colorado Gefitinib sensitivity-related gene expression and products and methods related thereto
EP2527460B1 (en) * 2004-05-27 2014-12-24 The Regents of The University of Colorado Methods for prediction of clinical outcome to epidermal growth factor receptor inhibitors by cancer patients
KR20080003334A (ko) * 2005-03-11 2008-01-07 더 리젠트스 오브 더 유니버시티 오브 콜로라도 암 세포를 표피 성장 인자 억제제에 대해 감작화시키는히스톤 데아세틸라제 억제제
US7504225B2 (en) 2005-05-12 2009-03-17 Applied Genomics, Inc. Reagents and methods for use in cancer diagnosis, classification and therapy
US20070091109A1 (en) 2005-09-13 2007-04-26 Roscoe Atkinson Image quality
US7993918B2 (en) * 2006-08-04 2011-08-09 Anthrogenesis Corporation Tumor suppression using placental stem cells
CA2667359C (en) 2006-10-23 2014-07-22 Anthrogenesis Corporation Methods and compositions for treatment of bone defects with placental cell populations
CA2858359C (en) 2006-11-01 2018-04-03 Ventana Medical Systems, Inc. Haptens, hapten conjugates, compositions thereof and method for their preparation and use
US9697582B2 (en) 2006-11-16 2017-07-04 Visiopharm A/S Methods for obtaining and analyzing images
WO2010017822A1 (en) 2008-08-15 2010-02-18 Visiopharm A/S A method and a system for determining a target in a biological sample by image analysis
WO2008100497A1 (en) 2007-02-12 2008-08-21 Anthrogenesis Corporation Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations
JP5663873B2 (ja) * 2007-03-01 2015-02-04 日本電気株式会社 乳癌病理画像診断支援システム、乳癌病理画像診断支援方法、乳癌病理画像診断支援プログラム、及び、乳癌病理画像診断支援プログラムを記録した記録媒体
US7985557B2 (en) 2007-05-23 2011-07-26 Ventana Medical Systems, Inc. Polymeric carriers for immunohistochemistry and in situ hybridization
KR101573026B1 (ko) 2007-07-25 2015-11-30 에자이 알앤드디 매니지먼트 가부시키가이샤 암 치료에서 이용하기 위한 멀티키나아제 억제제
US9200253B1 (en) 2007-08-06 2015-12-01 Anthrogenesis Corporation Method of producing erythrocytes
WO2009058908A2 (en) * 2007-10-29 2009-05-07 Eisai R & D Management Co., Ltd. Methods for prognosing the ability of a zearalenone analog compound to treat cancer
US8703490B2 (en) 2008-06-05 2014-04-22 Ventana Medical Systems, Inc. Compositions comprising nanomaterials and method for using such compositions for histochemical processes
CA2734446C (en) 2008-08-22 2017-06-20 Anthrogenesis Corporation Methods and compositions for treatment of bone defects with placental cell populations
GB2464747B (en) * 2008-10-10 2013-05-15 Hai Kang Life Corp Ltd Method for detection of analyte in microarray of samples and apparatus for performing such method
CA2749846C (en) 2009-01-15 2018-08-07 Laboratory Corporation Of America Holdings Methods of determining patient response by measurement of her-3
CN102341709A (zh) 2009-03-04 2012-02-01 霍夫曼-拉罗奇有限公司 作为肺鳞状细胞癌标志物的丝氨酸蛋白酶抑制蛋白b13
EP2438443A4 (en) * 2009-06-02 2012-07-25 Targeted Molecular Diagnostics Llc METHOD FOR DETECTING AND QUANTIFYING THE P95 COMPONENT OF HER2 / NEU (ERBB2)
MX353489B (es) 2009-07-02 2018-01-16 Anthrogenesis Corp Metodo para producir eritrocitos sin celulas alimentadoras.
JP5490568B2 (ja) * 2010-02-26 2014-05-14 オリンパス株式会社 顕微鏡システム、標本観察方法およびプログラム
KR20130092394A (ko) 2010-04-08 2013-08-20 안트로제네시스 코포레이션 태반 줄기 세포를 사용한 사르코이드증의 치료
US8524239B2 (en) 2010-07-09 2013-09-03 The United States of America as represented by the Secrectary, Department of Health and Human Services Photosensitizing antibody-fluorophore conjugates
TW201302793A (zh) 2010-09-03 2013-01-16 Glaxo Group Ltd 新穎之抗原結合蛋白
WO2012092485A1 (en) 2010-12-31 2012-07-05 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory rna molecules
US9092850B2 (en) * 2011-01-21 2015-07-28 Carnegie Mellon University Identifying location biomarkers
WO2012166844A2 (en) 2011-06-01 2012-12-06 Anthrogenesis Corporation Treatment of pain using placental stem cells
US20130338014A1 (en) * 2012-04-05 2013-12-19 Vala Sciences, Inc. Calibration Standards For Digital Histocytometry
CA2877315A1 (en) * 2012-06-20 2013-12-27 Merrimack Pharmaceuticals, Inc. Marker quantitation in single cells in tissue sections
JP6796058B2 (ja) 2014-08-08 2020-12-02 ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ インビトロおよびインビボにおける標的の光制御除去
US10304188B1 (en) 2015-03-27 2019-05-28 Caleb J. Kumar Apparatus and method for automated cell analysis
CN121270700A (zh) 2015-08-07 2026-01-06 美国政府(由卫生和人类服务部的部长所代表) 用于治疗癌症的针对抑制细胞的近红外光免疫疗法(nir-pit)
JP7085995B2 (ja) 2015-08-18 2022-06-17 ラクテン・メディカル，インコーポレイテッド 光免疫療法のための組成物、組み合わせおよび関連方法
SG10202011033QA (en) 2015-08-18 2020-12-30 Rakuten Medical Inc Phthalocyanine dye conjugates and their storage
WO2018119211A1 (en) * 2016-12-23 2018-06-28 Bio-Rad Laboratories, Inc. Reduction of background signal in blot images
WO2018207361A1 (ja) * 2017-05-12 2018-11-15 オリンパス株式会社 細胞画像取得装置
KR102854858B1 (ko) 2018-06-01 2025-09-03 라쿠텐 메디칼, 인크. 프탈로시아닌 염료 접합체 조성물
US20220211657A1 (en) * 2019-05-14 2022-07-07 Georgetown University Methods of treating gastrointestinal cancers and tumors thereof using combination therapy
CN118609852B (zh) * 2024-06-09 2024-11-22 中南大学 基于可解释模型预测感染性休克者亚甲蓝治疗响应的方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5086476A (en) 1985-11-04 1992-02-04 Cell Analysis Systems, Inc. Method and apparatus for determining a proliferation index of a cell sample
US4741043B1 (en) * 1985-11-04 1994-08-09 Cell Analysis Systems Inc Method of and apparatus for image analyses of biological specimens
US5008185A (en) 1985-11-04 1991-04-16 Cell Analysis Systems, Inc. Methods and apparatus for the quantitation of nuclear proteins
US5109429A (en) 1985-11-04 1992-04-28 Cell Analysis Systems,Inc. Apparatus and method for analyses of biological specimens
US5202931A (en) 1987-10-06 1993-04-13 Cell Analysis Systems, Inc. Methods and apparatus for the quantitation of nuclear protein
US5389523A (en) * 1988-05-31 1995-02-14 The United States Of Americas, As Represented By The Secretary Of Commerce Liposome immunoanalysis by flow injection assay
US5571714A (en) * 1988-12-22 1996-11-05 Celtrix Pharmaceuticals, Inc. Monoclonal antibodies which bind both transforming growth factors β1 and β2 and methods of use
EP0378383A3 (en) * 1989-01-10 1991-09-11 ARIZONA BOARD OF REGENTS, on behalf of THE UNIVERSITY OF ARIZONA Method and device for detection, validation and quantitation of multiple-drug resistance-associated antigens
US5784162A (en) * 1993-08-18 1998-07-21 Applied Spectral Imaging Ltd. Spectral bio-imaging methods for biological research, medical diagnostics and therapy
EP0656367A1 (en) 1991-08-22 1995-06-07 Becton, Dickinson and Company Method and composition for cancer therapy and for prognosticating responses to cancer theraphy
ES2161715T3 (es) * 1992-03-04 2001-12-16 Univ California Hibridacion genomica comparativa (hgc).
CA2094341A1 (en) * 1992-04-28 1993-10-29 Carl W. Porter Methods for the use of spermidine/spermine n1-acetyltransferase as a prognostic indicator and/or tumor response marker
US5536642A (en) * 1993-09-09 1996-07-16 Barbera-Guillem; Emilio Diagnostic and prognostic methods for solid non-lymphoid tumors and their metastases
US5491069A (en) * 1994-02-18 1996-02-13 The Regents Of The University Of California Biomarkers of cell senescence
US6463438B1 (en) * 1994-06-03 2002-10-08 Urocor, Inc. Neural network for cell image analysis for identification of abnormal cells
US5846749A (en) * 1994-10-12 1998-12-08 The Regents Of The University Of California Quantitative measurement of tissue protein identified by immunohistochemistry and standardized protein determination
US5998151A (en) * 1995-12-01 1999-12-07 The United States Of America As Represented By The Department Of Health And Human Services Methods for predicting the efficacy of a chemotherapeutic regimen for gastrointestinal cancers using antibodies specific for thymidylate synthase
US6165734A (en) * 1995-12-12 2000-12-26 Applied Spectral Imaging Ltd. In-situ method of analyzing cells
US5972622A (en) * 1996-02-08 1999-10-26 Desjardins; Louise Method of detecting apoptosis using an anti-human GP46 monoclonal anti-body
US5935801A (en) * 1996-03-29 1999-08-10 Dana-Farber Cancer Institute Monoclonal antibody that detects apoptotic antigen
US6447997B1 (en) * 1997-07-18 2002-09-10 Research Development Foundation Gene coding for GADD153 as a clinical diagnostic and prognostic in cancer therapy
CA2305681C (en) * 1997-09-30 2013-01-08 Peviva Ab Apoptosis-related compounds and their use
WO1999024620A1 (en) * 1997-11-10 1999-05-20 The Regents Of The University Of California Biochemical methods for detecting cervical dysplasia and cancer
US5852035A (en) * 1997-12-12 1998-12-22 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to substituted N- arylmethyl and heterocyclmethyl-1H-pyrazolo (3,4-B) quinolin-4-amines
DE69937835T2 (de) * 1998-09-24 2009-01-02 Promega Corp., Madison Antikörper für apoptosemarker und anwendungsverfahren
EP1131628A4 (en) * 1998-10-21 2004-05-12 Steven Jay Smith PROTEIN QUANTIFICATION WITH DENSITROMETRIC CELL IMAGE
US6372895B1 (en) * 2000-07-07 2002-04-16 3M Innovative Properties Company Fluorogenic compounds
EP1414995A2 (en) * 2000-12-21 2004-05-06 Board Of Trustees Of The University Of Illinois Reagents and methods for identifying and modulating expression of tumor senescence genes

Also Published As

Publication number Publication date
WO2001051924A3 (en) 2002-01-10
CA2397772C (en) 2007-06-12
US20010049114A1 (en) 2001-12-06
CA2397772A1 (en) 2001-07-19
EP1247097A2 (en) 2002-10-09
EP1247097B1 (en) 2004-07-21
AU2951801A (en) 2001-07-24
JP2003519795A (ja) 2003-06-24
EP1247098A1 (en) 2002-10-09
ATE271691T1 (de) 2004-08-15
JP3699399B2 (ja) 2005-09-28
AU785347B2 (en) 2007-02-01
CA2397417A1 (en) 2001-07-19
WO2001051928A1 (en) 2001-07-19
DE60104392D1 (de) 2004-08-26
JP2003519796A (ja) 2003-06-24
US6962789B2 (en) 2005-11-08
MXPA02006843A (es) 2004-04-05
WO2001051924A2 (en) 2001-07-19
US20010044124A1 (en) 2001-11-22
AU2788701A (en) 2001-07-24
DK1247097T3 (da) 2004-11-29
DE60104392T2 (de) 2005-08-11
US7833698B2 (en) 2010-11-16
WO2001051928A9 (en) 2002-10-24

Similar Documents

Publication Publication Date Title
MXPA02006778A (es) Metodo para determinar la respuesta a una terapia de cancer.
BR0109350B1 (pt) bomba de êmbolo.
NO20054076L (no) Boresko.
BR0215948B1 (pt) bomba de pré-compressão.
ITTO20030626A1 (it) Vacuometro a ionizzazione.
NO20052149D0 (no) Vaksine.
ITTO20030627A1 (it) Vacuometro a ionizzazione.
ITRM20000561A0 (it) Metodo per identificare in vivo epitopi intracellulari.
IT1318673B1 (it) Farmaci per le disfunzioni sessuali.
ITBO20030715A1 (it) Calzatura.
ITMI20022389A1 (it) Farmaci per le disfunzioni sessuali.
NO20053189D0 (no) HVC-kombinasjonsterapi.
ITBG20020034A1 (it) Struttura di pattino migliorata.
ES1055700Y (es) Rotulo luminoso.
ES1051849Y (es) Aerostato publicitario.
ITMO20030067A0 (it) Macchina incappucciatrice combinata.
BR8300037Y1 (pt) dispositivo de conformação para calçados em geral.
ITMI20020453A1 (it) Meccanismo di punzone per macchina i.s.
ES1055919Y (es) Punzon hidraulico.
ITRM20020020U1 (it) Contenitore - distributore per monete.
ITRM20020328A1 (it) Matrici per dnaser.
ITBO20020533A1 (it) Decoro scanalato.
ES1052110Y (es) Zapatilla de un solo uso.
ES1055534Y (es) Guias para forjados en construccion.
ITVR20030001A1 (it) Chiodo ad elica.

Legal Events

Date Code Title Description
FG Grant or registration